C

China National Medicines Corp Ltd
SSE:600511

Watchlist Manager
China National Medicines Corp Ltd
SSE:600511
Watchlist
Price: 34.38 CNY -0.12% Market Closed
Market Cap: 25.9B CNY
Have any thoughts about
China National Medicines Corp Ltd?
Write Note

China National Medicines Corp Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

China National Medicines Corp Ltd
Accounts Payable Peer Comparison

Comparables:
1099
601607
600998
000963
Q
301015

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
C
China National Medicines Corp Ltd
SSE:600511
Accounts Payable
ÂĄ9.3B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
20%
Sinopharm Group Co Ltd
HKEX:1099
Accounts Payable
ÂĄ156.6B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
12%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Accounts Payable
ÂĄ47.9B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
11%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Accounts Payable
ÂĄ18.2B
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
14%
Huadong Medicine Co Ltd
SZSE:000963
Accounts Payable
ÂĄ4.8B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
7%
Q
Qingdao Baheal Medical Inc
SZSE:301015
Accounts Payable
ÂĄ625.8m
CAGR 3-Years
-4%
CAGR 5-Years
6%
CAGR 10-Years
N/A

See Also

What is China National Medicines Corp Ltd's Accounts Payable?
Accounts Payable
9.3B CNY

Based on the financial report for Jun 30, 2024, China National Medicines Corp Ltd's Accounts Payable amounts to 9.3B CNY.

What is China National Medicines Corp Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
20%

Over the last year, the Accounts Payable growth was -2%. The average annual Accounts Payable growth rates for China National Medicines Corp Ltd have been 3% over the past three years , 4% over the past five years , and 20% over the past ten years .

Back to Top